Cargando…
Altered Plasma Lysophosphatidylcholines and Amides in Non-Obese and Non-Diabetic Subjects with Borderline-To-Moderate Hypertriglyceridemia: A Case-Control Study
Hypertriglyceridemia (HTG) is a risk factor for atherosclerotic cardiovascular disease (CVD). We investigated alterations in plasma metabolites associated with borderline-to-moderate HTG (triglycerides (TG) 150-500 mg/dL). Using UPLC-LTQ-Orbitrap mass spectrometry analysis, the metabolomics profiles...
Autores principales: | Lee, Sae Young, Kim, Minjoo, Jung, Saem, Lee, Sang-Hyun, Lee, Jong Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391846/ https://www.ncbi.nlm.nih.gov/pubmed/25856314 http://dx.doi.org/10.1371/journal.pone.0123306 |
Ejemplares similares
-
Alterations of Plasma Lysophosphatidylcholine Species in Obesity and Weight Loss
por: Heimerl, Susanne, et al.
Publicado: (2014) -
Association between Arterial Stiffness and Serum L-Octanoylcarnitine and Lactosylceramide in Overweight Middle-Aged Subjects: 3-Year Follow-Up Study
por: Kim, Minjoo, et al.
Publicado: (2015) -
Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes
por: Barber, Melissa N., et al.
Publicado: (2012) -
Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity
por: Wang, Yang, et al.
Publicado: (2019) -
Global Metabolic Profiling of Plasma Shows that Three-Year Mild-Caloric Restriction Lessens an Age-Related Increase in Sphingomyelin and Reduces L-leucine and L-phenylalanine in Overweight and Obese Subjects
por: Kim, Minjoo, et al.
Publicado: (2016)